Literature DB >> 22954017

Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.

Jeffrey R Garber1, Rhoda H Cobin, Hossein Gharib, James V Hennessey, Irwin Klein, Jeffrey I Mechanick, Rachel Pessah-Pollack, Peter A Singer, Kenneth A Woeber.   

Abstract

BACKGROUND: Hypothyroidism has multiple etiologies and manifestations. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions. This paper describes evidence-based clinical guidelines for the clinical management of hypothyroidism in ambulatory patients.
METHODS: The development of these guidelines was commissioned by the American Association of Clinical Endocrinologists (AACE) in association with American Thyroid Association (ATA). AACE and the ATA assembled a task force of expert clinicians who authored this article. The authors examined relevant literature and took an evidence-based medicine approach that incorporated their knowledge and experience to develop a series of specific recommendations and the rationale for these recommendations. The strength of the recommendations and the quality of evidence supporting each was rated according to the approach outlined in the American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Guidelines-2010 update.
RESULTS: Topics addressed include the etiology, epidemiology, clinical and laboratory evaluation, management, and consequences of hypothyroidism. Screening, treatment of subclinical hypothyroidism, pregnancy, and areas for future research are also covered.
CONCLUSIONS: Fifty-two evidence-based recommendations and subrecommendations were developed to aid in the care of patients with hypothyroidism and to share what the authors believe is current, rational, and optimal medical practice for the diagnosis and care of hypothyroidism. A serum thyrotropin is the single best screening test for primary thyroid dysfunction for the vast majority of outpatient clinical situations. The standard treatment is replacement with L-thyroxine. The decision to treat subclinical hypothyroidism when the serum thyrotropin is less than 10 mIU/L should be tailored to the individual patient.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22954017     DOI: 10.1089/thy.2012.0205

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  224 in total

1.  Response.

Authors:  Justin M Oldham; Mary E Strek; Imre Noth
Journal:  Chest       Date:  2016-02       Impact factor: 9.410

2.  Do Not Forget Nephrotic Syndrome as a Cause of Increased Requirement of Levothyroxine Replacement Therapy.

Authors:  Salvatore Benvenga; Roberto Vita; Flavia Di Bari; Poupak Fallahi; Alessandro Antonelli
Journal:  Eur Thyroid J       Date:  2015-05-28

Review 3.  Endocrinological aspects of HIV infection.

Authors:  F S Mirza; P Luthra; L Chirch
Journal:  J Endocrinol Invest       Date:  2018-01-08       Impact factor: 4.256

Review 4.  Thyroid hormone therapy for subclinical hypothyroidism.

Authors:  Flavia Magri; Luca Chiovato; Laura Croce; Mario Rotondi
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

5.  Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.

Authors:  Salvatore Benvenga; Flavia Di Bari; Roberto Vita
Journal:  Endocrine       Date:  2017-02-03       Impact factor: 3.633

6.  Oxidative stress in patients with thyroidectomy and thyroparathyroidectomy under replacement therapy.

Authors:  Murat Kaçmaz; Murat Atmaca; Ayşe Arslan; Halit Demir; Mehmet Fatih Özbay
Journal:  Endocrine       Date:  2014-04-24       Impact factor: 3.633

Review 7.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

Review 8.  Thyroid hormone therapy for hypothyroidism.

Authors:  Bernadette Biondi; David S Cooper
Journal:  Endocrine       Date:  2019-08-01       Impact factor: 3.633

9.  Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care.

Authors:  Valeria Guglielmi; Alfonso Bellia; Elisa Bianchini; Gerardo Medea; Iacopo Cricelli; Paolo Sbraccia; Davide Lauro; Claudio Cricelli; Francesco Lapi
Journal:  Endocrine       Date:  2017-09-14       Impact factor: 3.633

10.  Use of thyroid-stimulating hormone tests for identifying primary hypothyroidism in family medicine patients.

Authors:  Elizabeth Birk-Urovitz; M Elisabeth Del Giudice; Christopher Meaney; Karan Grewal
Journal:  Can Fam Physician       Date:  2017-09       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.